𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients

✍ Scribed by Michael Fiegl; Florian Falkner; Michael Steurer; Niklas Zojer; Georg Hopfinger; Ferdinand Haslbauer; Guntram Winder; Daniela Voskova; Johannes Andel; Alois Lang; Yvona Brychtova; Jiri Mayer; Richard Greil; Günther Gastl; for The Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia, in cooperation with The Czech Leukemia Study Group for Life, CELL

Book ID
105989830
Publisher
Springer
Year
2011
Tongue
English
Weight
240 KB
Volume
90
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Routine clinical use of alemtuzumab in p
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia : A nation-wide retrospective study in Austria
✍ Michael Fiegl; Andreas Falkner; Georg Hopfinger; Stefan Brugger; August Zabernig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract ## BACKGROUND. In previous studies, alemtuzumab demonstrated considerable activity in patients with previously treated B‐cell chronic lymphocytic leukemia (CLL), including fludarabine‐refractory disease. In this retrospective study, the authors evaluated the benefit of alemtuzumab mono